<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00661037</url>
  </required_header>
  <id_info>
    <org_study_id>2007_SI</org_study_id>
    <nct_id>NCT00661037</nct_id>
  </id_info>
  <brief_title>SAFEty of Two Strategies of ICD Management at Implantation</brief_title>
  <acronym>SAFE-ICD</acronym>
  <official_title>SAFEty of Two Strategies of ICD Management at Implantation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boston Scientific Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Boston Scientific Corporation</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this prospective observational study is to evaluate the safety, over a follow-up
      of 2 years, of two strategies, consisting in performing or not performing defibrillation
      testing(DT) during first implant of implantable cardioverter defibrillator
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The standardized requirements for implantable cardioverter defibrillator (ICD) include
      defibrillation testing (DT), consisting in induction and termination of ventricular
      fibrillation (VF). An effective DT has historically been considered part of standard
      procedures at implant. Nevertheless, implant techniques and technology have evolved during
      years and nowadays deviations are frequent in clinical practice mainly due to the fact that
      physicians are seriously concerned about the risk of severe complications related to DT.
      However, the practice of not performing DT is arbitrary and its safety is yet unproven. This
      observational study will assess the safety of the two strategies adopted at ICD implant:
      induction (including patients who undergo DT at implant) and non-induction (including
      patients who do not undergo DT at implant. No deviation from the centres' current practice in
      choosing to perform or not perform DT is introduced by this study protocol. The study
      considers consecutive patients undergoing first implant of ICD
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2008</start_date>
  <completion_date type="Actual">September 2011</completion_date>
  <primary_completion_date type="Actual">May 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants With Severe Intra-operative Complications at ICD Implant and/or Events at Follow up</measure>
    <time_frame>2 years</time_frame>
    <description>Severe implant-related* complications at ICD implants among the following:
Survival from cardiopulmonary arrest due to VF requiring 3 or more consecutive external shocks for termination or due to electro-mechanical dissociation.
Transient ischemic attack or stroke,
Cardiogenic shock,
Pulmonary edema,
Embolic events,
Anoxic coma
Pericardial tamponade
Death.
Events at follow up:
Sudden cardiac death (defined as witnessed unexpected death occurring &lt;1 hour from symptoms onset or unwitnessed during sleep)
Resuscitation after ineffective documented appropriate ICD shocks
Implant related events are considered as those listed above, occurring during the implant procedure in the timeframe betweend device poket insertion and patient exit from the cath-lab, as well as those events occurring after the patient exit from the cath-lab that, after review from the event adjudication committee, have been classified as related to the implant procedure.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Severe Intra-operative Complications</measure>
    <time_frame>Acute (ICD implant)</time_frame>
    <description>including: cardiopulmonary arrest, transient ischemic attack or stroke, cardiogenic shock, pulmonary edema, embolic event, anoxic coma, pericardial tamponade,death</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sudden Cardiac Death at Follow up or Resusciation After Ineffective Documented Appropriate ICD Shocks at Follow up</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">2120</enrollment>
  <condition>Ventricular Fibrillation</condition>
  <condition>Ventricular Flutter</condition>
  <condition>Sudden Cardiac Death</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <description>Patients having VF induction with shock termination at implant</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <description>Patients not having VF induction at implant or during follow-up</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Implantable defibrillator</intervention_name>
    <description>Implantable defibrillator to reduce ventricular arrhythmias via shock.</description>
    <arm_group_label>1</arm_group_label>
    <other_name>Not applicable. All devices allowed.</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Implantable defibrillator</intervention_name>
    <description>Implantable defibrillator to reduce ventricular arrhythmias via shock.</description>
    <arm_group_label>2</arm_group_label>
    <other_name>Not applicable. All devices allowed.</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All patients having the risk of life threatening arrhythmias and indicated for the implant
        of an implantable cardioverter defibrillator.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  first implantation of ICD or CRT-D

          -  Patients undergoing upgrade to ICD or CRT-D from pacemaker

          -  Patients undergoing upgrade to CRT-D from CRT

          -  Age 18 or above, or legal age to give written informed consent

        Exclusion Criteria:

          -  Patients who do not give consent to treat their data.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michele Brignole, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Ospedali del Tigullio</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ospedali del Tigullio, via Don Bobbio 25</name>
      <address>
        <city>Lavagna</city>
        <zip>16033</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 7, 2008</study_first_submitted>
  <study_first_submitted_qc>April 17, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 18, 2008</study_first_posted>
  <results_first_submitted>February 20, 2017</results_first_submitted>
  <results_first_submitted_qc>April 6, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">June 20, 2017</results_first_posted>
  <last_update_submitted>June 22, 2017</last_update_submitted>
  <last_update_submitted_qc>June 22, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 21, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Death</mesh_term>
    <mesh_term>Death, Sudden, Cardiac</mesh_term>
    <mesh_term>Ventricular Fibrillation</mesh_term>
    <mesh_term>Ventricular Flutter</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>VF Induction</title>
          <description>Patients having VF induction with shock termination at implant (Implantable defibrillator: Implantable defibrillator to reduce ventricular arrhythmias via shock)</description>
        </group>
        <group group_id="P2">
          <title>no VF Induction</title>
          <description>Patients not having VF induction at implant or during follow-up
Implantable defibrillator: Implantable defibrillator to reduce ventricular arrhythmias via shock.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="836"/>
                <participants group_id="P2" count="1284"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Witdrawn</title>
              <participants_list>
                <participants group_id="P1" count="47"/>
                <participants group_id="P2" count="68"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Deaths</title>
              <participants_list>
                <participants group_id="P1" count="108"/>
                <participants group_id="P2" count="188"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="682"/>
                <participants group_id="P2" count="1027"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="154"/>
                <participants group_id="P2" count="257"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>VF Induction</title>
          <description>Patients having VF induction with shock termination at implant (Implantable defibrillator: Implantable defibrillator to reduce ventricular arrhythmias via shock)</description>
        </group>
        <group group_id="B2">
          <title>no VF Induction</title>
          <description>Patients not having VF induction at implant or during follow-up (Implantable defibrillator: Implantable defibrillator to reduce ventricular arrhythmias via shock)</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="836"/>
            <count group_id="B2" value="1284"/>
            <count group_id="B3" value="2120"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="66" spread="12"/>
                    <measurement group_id="B2" value="67" spread="11"/>
                    <measurement group_id="B3" value="66" spread="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="152"/>
                    <measurement group_id="B2" value="268"/>
                    <measurement group_id="B3" value="420"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="684"/>
                    <measurement group_id="B2" value="1016"/>
                    <measurement group_id="B3" value="1700"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Italy</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="836"/>
                    <measurement group_id="B2" value="1284"/>
                    <measurement group_id="B3" value="2120"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Severe Intra-operative Complications at ICD Implant and/or Events at Follow up</title>
        <description>Severe implant-related* complications at ICD implants among the following:
Survival from cardiopulmonary arrest due to VF requiring 3 or more consecutive external shocks for termination or due to electro-mechanical dissociation.
Transient ischemic attack or stroke,
Cardiogenic shock,
Pulmonary edema,
Embolic events,
Anoxic coma
Pericardial tamponade
Death.
Events at follow up:
Sudden cardiac death (defined as witnessed unexpected death occurring &lt;1 hour from symptoms onset or unwitnessed during sleep)
Resuscitation after ineffective documented appropriate ICD shocks
Implant related events are considered as those listed above, occurring during the implant procedure in the timeframe betweend device poket insertion and patient exit from the cath-lab, as well as those events occurring after the patient exit from the cath-lab that, after review from the event adjudication committee, have been classified as related to the implant procedure.</description>
        <time_frame>2 years</time_frame>
        <group_list>
          <group group_id="O1">
            <title>VF Induction</title>
            <description>Patients having VF induction with shock termination at implant (Implantable defibrillator: Implantable defibrillator to reduce ventricular arrhythmias via shock)</description>
          </group>
          <group group_id="O2">
            <title>no VF Induction</title>
            <description>Patients not having VF induction at implant or during follow-up (Implantable defibrillator: Implantable defibrillator to reduce ventricular arrhythmias via shock)</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Severe Intra-operative Complications at ICD Implant and/or Events at Follow up</title>
          <description>Severe implant-related* complications at ICD implants among the following:
Survival from cardiopulmonary arrest due to VF requiring 3 or more consecutive external shocks for termination or due to electro-mechanical dissociation.
Transient ischemic attack or stroke,
Cardiogenic shock,
Pulmonary edema,
Embolic events,
Anoxic coma
Pericardial tamponade
Death.
Events at follow up:
Sudden cardiac death (defined as witnessed unexpected death occurring &lt;1 hour from symptoms onset or unwitnessed during sleep)
Resuscitation after ineffective documented appropriate ICD shocks
Implant related events are considered as those listed above, occurring during the implant procedure in the timeframe betweend device poket insertion and patient exit from the cath-lab, as well as those events occurring after the patient exit from the cath-lab that, after review from the event adjudication committee, have been classified as related to the implant procedure.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="836"/>
                <count group_id="O2" value="1284"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18"/>
                    <measurement group_id="O2" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Severe Intra-operative Complications</title>
        <description>including: cardiopulmonary arrest, transient ischemic attack or stroke, cardiogenic shock, pulmonary edema, embolic event, anoxic coma, pericardial tamponade,death</description>
        <time_frame>Acute (ICD implant)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>VF Induction</title>
            <description>Patients having VF induction with shock termination at implant (Implantable defibrillator: Implantable defibrillator to reduce ventricular arrhythmias via shock)</description>
          </group>
          <group group_id="O2">
            <title>no VF Induction</title>
            <description>Patients not having VF induction at implant or during follow-up (Implantable defibrillator: Implantable defibrillator to reduce ventricular arrhythmias via shock)</description>
          </group>
        </group_list>
        <measure>
          <title>Severe Intra-operative Complications</title>
          <description>including: cardiopulmonary arrest, transient ischemic attack or stroke, cardiogenic shock, pulmonary edema, embolic event, anoxic coma, pericardial tamponade,death</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="836"/>
                <count group_id="O2" value="1284"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Sudden Cardiac Death at Follow up or Resusciation After Ineffective Documented Appropriate ICD Shocks at Follow up</title>
        <time_frame>2 years</time_frame>
        <group_list>
          <group group_id="O1">
            <title>VF Induction</title>
            <description>Patients having VF induction with shock termination at implant</description>
          </group>
          <group group_id="O2">
            <title>No- VF Induction</title>
            <description>Patients not having VF induction at implant or during follow-up</description>
          </group>
        </group_list>
        <measure>
          <title>Sudden Cardiac Death at Follow up or Resusciation After Ineffective Documented Appropriate ICD Shocks at Follow up</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="836"/>
                <count group_id="O2" value="1284"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                    <measurement group_id="O2" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>2 years</time_frame>
      <desc>Adverse Events were assessed without regard to the specific Adverse Event Terms but classified withing the boundaries of ISO classfication: Adverse Event (AE); Adverse Device Effect (ADE); Serious Adverse Event (SAE): Serious Adverse Device Effect (SADE)</desc>
      <group_list>
        <group group_id="E1">
          <title>VF Induction</title>
          <description>Patients having VF induction with shock termination at implant (Implantable defibrillator: Implantable defibrillator to reduce ventricular arrhythmias via shock)</description>
        </group>
        <group group_id="E2">
          <title>no VF Induction</title>
          <description>Patients not having VF induction at implant or during follow-up (Implantable defibrillator: Implantable defibrillator to reduce ventricular arrhythmias via shock)</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="108" subjects_at_risk="836"/>
                <counts group_id="E2" subjects_affected="188" subjects_at_risk="1284"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="209" subjects_at_risk="836"/>
                <counts group_id="E2" subjects_affected="177" subjects_at_risk="1284"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>SAE-serious adverse events</sub_title>
                <counts group_id="E1" events="222" subjects_affected="146" subjects_at_risk="836"/>
                <counts group_id="E2" events="205" subjects_affected="133" subjects_at_risk="1284"/>
              </event>
              <event>
                <sub_title>SADE - serious adverse device effects</sub_title>
                <counts group_id="E1" events="107" subjects_affected="63" subjects_at_risk="836"/>
                <counts group_id="E2" events="74" subjects_affected="44" subjects_at_risk="1284"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="120" subjects_at_risk="836"/>
                <counts group_id="E2" subjects_affected="90" subjects_at_risk="1284"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>AE - Adverse Events (Non serious / non device related)</sub_title>
                <counts group_id="E1" events="53" subjects_affected="42" subjects_at_risk="836"/>
                <counts group_id="E2" events="53" subjects_affected="44" subjects_at_risk="1284"/>
              </event>
              <event>
                <sub_title>ADE - non serious adverse device effects</sub_title>
                <counts group_id="E1" events="126" subjects_affected="78" subjects_at_risk="836"/>
                <counts group_id="E2" events="70" subjects_affected="46" subjects_at_risk="1284"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr Michele Brignole</name_or_title>
      <organization>Ospedali del Tigullio, Lavagna, Italy</organization>
      <phone>0185 329567329 ext 0039</phone>
      <email>aritmo@asl4.liguria.it</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

